245 related articles for article (PubMed ID: 21713341)
41. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
42. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
Balázs M; Carroll P; Kerschmann R; Sauter G; Waldman FM
Genes Chromosomes Cancer; 1997 Jun; 19(2):84-9. PubMed ID: 9171998
[TBL] [Abstract][Full Text] [Related]
43. [Detection of chromosomal aberration using fluorescence in situ hybridization in DNA diploid colorectal carcinomas].
Jibiki M; Tagawa Y; Miyashita K; Hara S; Yasutake T; Nakazaki T; Obatake M; Sawai T; Morinaga M; Akama F
Gan To Kagaku Ryoho; 1993 Apr; 20(6):759-62. PubMed ID: 8489281
[TBL] [Abstract][Full Text] [Related]
44. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
[TBL] [Abstract][Full Text] [Related]
46. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
[TBL] [Abstract][Full Text] [Related]
47. Aurora kinase B expression in breast carcinoma: cell kinetic and genetic aspects.
Hegyi K; Egervári K; Sándor Z; Méhes G
Pathobiology; 2012; 79(6):314-22. PubMed ID: 22688343
[TBL] [Abstract][Full Text] [Related]
48. Cytogenetic alterations in chagasic achalasia compared to esophageal carcinoma.
Manoel-Caetano Fda S; Borim AA; Caetano A; Cury PM; Silva AE
Cancer Genet Cytogenet; 2004 Feb; 149(1):17-22. PubMed ID: 15104278
[TBL] [Abstract][Full Text] [Related]
49. Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression.
Li X; Tsuji T; Wen S; Mimura Y; Sasaki K; Shinozaki F
Cancer; 1997 Jun; 79(12):2314-9. PubMed ID: 9191518
[TBL] [Abstract][Full Text] [Related]
50. Detection of numerical abnormalities of chromosome 9 and p16/CDKN2A gene alterations in ovarian cancer with fish analysis.
Aravidis C; Panani AD; Kosmaidou Z; Thomakos N; Rodolakis A; Antsaklis A
Anticancer Res; 2012 Dec; 32(12):5309-13. PubMed ID: 23225431
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique.
Yakut T; Bekar A; Doygun M; Acar H; Egeli U; Ogul E
Teratog Carcinog Mutagen; 2002; 22(3):217-25. PubMed ID: 11948632
[TBL] [Abstract][Full Text] [Related]
52. Frequency of chromosome 17 aneuploidy in primary and recurrent pterygium by interphase-fluorescence in situ hybridization.
Kamis U; Kerimoglu H; Ozkagnici A; Acar H
Ophthalmic Res; 2006; 38(2):89-94. PubMed ID: 16357492
[TBL] [Abstract][Full Text] [Related]
53. [Detection of chromosomal numerical aberration in glioma by FISH (fluorescence in situ hybridization)].
Kasai H; Imahori T; Kawamoto K
Hum Cell; 1993 Mar; 6(1):62-5. PubMed ID: 8343450
[TBL] [Abstract][Full Text] [Related]
54. Chromosome 9 and 17 aberrations and p53 gene deletion detected by fluorescence in situ hybridization in renal-cell carcinoma.
Yoshioka K; Nakamura S
Mol Urol; 2001; 5(1):11-7. PubMed ID: 11689146
[TBL] [Abstract][Full Text] [Related]
55. Interrelationship between TP53 gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma.
Khayat AS; Guimarães AC; Calcagno DQ; Seabra AD; Lima EM; Leal MF; Faria MH; Rabenhorst SH; Assumpção PP; Demachki S; Smith MA; Burbano RR
BMC Gastroenterol; 2009 Jul; 9():55. PubMed ID: 19619279
[TBL] [Abstract][Full Text] [Related]
56. Somatic DNA alterations in endometriosis: high frequency of chromosome 17 and p53 loss in late-stage endometriosis.
Bischoff FZ; Heard M; Simpson JL
J Reprod Immunol; 2002; 55(1-2):49-64. PubMed ID: 12062821
[TBL] [Abstract][Full Text] [Related]
57. [Correlation between aneuploidy of chromosome 17, over-expression of TP53 and TOPIIalpha, and the clinicopathological features and diagnosis of gastric adenocarcinoma].
Lu HZ; Wu YP; Luo W; Han YL; Cai Y; Xu X; Liang J; Liu SM; Wang MR
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):754-8. PubMed ID: 20021828
[TBL] [Abstract][Full Text] [Related]
58. c-MYC, RB-1, TP53, and centromere 8 and 17 copy number in B-cell non-Hodgkin's lymphomas assessed by dual-color fluorescence in situ hybridization.
Galteland E; Holte H; Stokke T
Cytometry; 1999 Apr; 38(2):53-60. PubMed ID: 10323217
[TBL] [Abstract][Full Text] [Related]
59. Chromosome 17 copy numbers and incidence of p 53 gene deletion in gastric cancer cells. Dual color fluorescence in situ hybridization analysis.
Suzuki S; Tenjin T; Shibuya T; Tanaka S
Nihon Ika Daigaku Zasshi; 1997 Feb; 64(1):22-9. PubMed ID: 9119949
[TBL] [Abstract][Full Text] [Related]
60. Chromosome aberrations in renal tumors detected by fluorescence in situ hybridization.
Wada Y; Yokogi H; Moriyama-Gonda N; Shigeno K; Shiina H; Igawa M
Cancer Genet Cytogenet; 1997 Nov; 99(1):38-44. PubMed ID: 9352794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
